San Diego Pier

PharmaMES USA – Matt Gresh, & Cory Brown from National Resilience, Inc

Pharma MES USA – Matt Gresh, & Cory Brown from National Resilience, Inc

This video discusses the considerations and benefits of investing in POMSnet Aquila Manufacturing Execution System (MES) for Life Sciences processes. Key points include reducing cost, time, and risk by standardizing workflows and achieving goals like auto-releasing batches. It outlines the project timeline, criteria for choosing an MES, and emphasizes total cost of ownership, vendor validation, team support, and infrastructure alignment.